The bill amends existing Florida statutes to enhance the availability and definition of emergency opioid antagonists in public K-12 schools and postsecondary educational institutions. Specifically, it allows public schools to purchase, use, and maintain a supply of emergency opioid antagonists that meet certain criteria, rather than being limited to naloxone. The bill also revises the definition of "emergency opioid antagonist" to include any drug approved by the United States Food and Drug Administration for the emergency treatment of an opioid overdose, rather than exclusively naloxone.

Additionally, the bill ensures that school district employees who administer an approved emergency opioid antagonist to a student in compliance with relevant statutes are granted immunity from civil liability. The changes aim to improve the response to opioid overdoses in educational settings, thereby enhancing student safety. The act is set to take effect on July 1, 2025.

Statutes affected:
H 355 Filed: 1002.20, 1004.0971